Compliance & Validation — Not documented by Atlas
Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?
Digital chemistry platform uniting AI, robotics, and 'chemputation' to design and synthesize small molecules from code.
Chemify, founded in 2022 as a spin-out of the University of Glasgow and headquartered in Glasgow, United Kingdom, combines AI, robotics, and its 'chemputation' approach to design small molecules directly from code and automate their synthesis, targeting drug discovery and advanced materials. The company raised an oversubscribed Series B of more than $50M. Atlas found no vendor-held security certifications documented on its site.
50% — Partial coverage. Coverage score — how completely Atlas documents Chemify across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.
Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?
cloud
Ask the vendor: What is your pricing model, and what drives total cost of ownership?
Ask the vendor: What is a realistic implementation timeline, and what onboarding support is included?
Biotech Startup, Mid-Size Biotech, Large Pharma, Drug Discovery, R&D Leadership
Molecular Generation
Series B, Founded 2022
Not captured in Atlas data — confirm directly. Excluded from the score above.
Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?
Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?